Swedish hygiene and health company Essity AB has agreed to acquire the Brazil-based feminine care business of American consumer health company Kenvue Inc. for approximately $284 million (around SEK 2.7 billion).
The acquisition includes three well-known feminine hygiene brands in Brazil: Carefree, Sempre Livre, and o.b. It also covers related manufacturing equipment and business operations in the country.
The deal was announced on August 19, 2026. Its main objective is to strengthen Essity’s position in Brazil’s feminine hygiene market. Brazil is already an important market for Essity, where the company sells incontinence care products through its TENA brand.
Important clarification: This is not an acquisition of the entire Kenvue company. Essity is acquiring only Kenvue’s Brazil-based feminine care business.
Kenvue has a separate proposed acquisition agreement with Kimberly-Clark Corporation, valued at approximately $40 billion. These are two different transactions and should not be confused.
Key Acquisition Details
| Deal Detail | Information |
| Acquirer | Essity AB |
| Target Business | Kenvue’s Feminine Care Business in Brazil |
| Seller | Kenvue Inc. / Certain Kenvue Subsidiaries |
| Deal Type | Business / Asset Acquisition |
| Announcement Date | August 19, 2026 |
| Deal Value | $284 Million |
| Approx. Value in Swedish Krona | SEK 2.7 Billion |
| Transaction Structure | Cash and debt-free basis |
| Brands Acquired | Carefree, Sempre Livre, o.b. |
| Business Location | Brazil |
| Acquirer Country | Sweden |
| Seller Country | USA |
| Expected Closing | Second Quarter of 2027 |
| Acquirer Stock Exchange | Nasdaq Stockholm |
| Acquirer Ticker | ESSITY B |
| Transaction Status | Announced and Pending |
Company Introduction: Essity AB
Headquarters: Stockholm, Sweden
Essity is a Swedish hygiene and health company. It manufactures and sells products across personal care, feminine care, incontinence care, medical solutions, and professional hygiene.
What Does Essity Do?
Essity’s products are designed to meet everyday hygiene and healthcare needs. Its major business areas include:
- Feminine Care: Sanitary pads, tampons, and panty liners.
- Incontinence Care: Products designed for people experiencing bladder leakage.
- Medical Solutions: Medical products for healthcare professionals and patients.
- Personal Care: Skin care and personal hygiene products.
- Professional Hygiene: Hygiene products used in offices, hospitals, hotels, and public places.
Some of Essity’s well-known brands include TENA, Tork, Libresse, Bodyform, Nana, Saba, Libra, and Nosotras.
Why Is Essity Interested in This Acquisition?
Essity already operates in the feminine care market. Acquiring Kenvue’s Brazil business will give it three established brands and access to related local manufacturing operations.
This provides Essity with an opportunity to expand its presence in Brazil’s feminine hygiene category.
Company Introduction: Kenvue Inc.
Headquarters: Summit, New Jersey, USA
Kenvue is an American consumer health company known for its personal care, skin health, self-care, and everyday healthcare products.
What Does Kenvue Do?
Kenvue’s portfolio includes several well-known consumer brands:
- Neutrogena: Skin care and beauty products.
- Aveeno: Skin care products and moisturizers.
- Listerine: Oral care products.
- BAND-AID Brand: Adhesive bandages and wound care products.
- Tylenol: Pain relief medicines.
- Johnson’s: Baby care products.
Kenvue’s business is not limited to feminine care. The Brazil-based business being sold to Essity represents only one part of its broader consumer health portfolio.
Why Is Kenvue Selling This Business?
Kenvue’s transaction announcement did not provide a detailed financial or strategic explanation for selling this particular business. Therefore, it would not be accurate to claim that the company is selling it because of financial pressure.
It is also important to remember that Kenvue has a separate agreement with Kimberly-Clark for the proposed acquisition of the entire company. The sale of its Brazil feminine care business to Essity is a separate business transaction.
Which Brands Will Essity Acquire?
The transaction includes three important feminine care brands.
Carefree
Carefree is primarily known for panty liners and feminine hygiene products. These products are designed for everyday freshness and light protection.
Sempre Livre
Sempre Livre is an established feminine hygiene brand in Brazil. Its products include sanitary pads and menstrual care products.
o.b.
o.b. is well known for its tampons and is an internationally recognized brand in the feminine hygiene category.
Under the transaction, Essity will acquire the Brazilian business associated with these three brands, along with related manufacturing equipment.
Understanding the $284 Million Deal Value
Essity will pay approximately $284 million, equivalent to around SEK 2.7 billion, for the acquisition. The purchase price has been announced on a cash and debt-free basis.
Note: The $284 million purchase price was announced on a cash and debt-free basis. It should not be interpreted simply as the amount of cash distributed to Kenvue shareholders because this is a business/asset acquisition rather than a purchase of Kenvue’s entire share capital.
Acquired Business Revenue
According to Essity’s official announcement, the acquired business generated approximately:
- BRL 800 million in net sales.
- Approximately SEK 1.4 billion in net sales.
These figures represent the last 12 months ended June 30, 2026. Essity also described the acquired business as having good profitability.
Financial Snapshot
| Financial Metric | Reported Information |
| Acquisition Value | $284 Million |
| Approx. Value in SEK | SEK 2.7 Billion |
| Last 12-Month Net Sales | BRL 800 Million |
| Approx. Net Sales in SEK | SEK 1.4 Billion |
| Reporting Period | 12 Months Ended June 30, 2026 |
| Profitability | Described as Good by Essity |
What Are the Potential Benefits?
Access to More Customers: The three established brands can help Essity reach different groups of customers.
Expanded Product Portfolio: Its presence in products such as sanitary pads, panty liners, and tampons will increase.
Manufacturing Capabilities: Acquiring related manufacturing equipment provides an opportunity to strengthen local production and supply chain operations.
Stronger Market Presence: The company could build a broader commercial presence in Brazil’s feminine care category.
How Does This Acquisition Relate to Essity’s Earlier Feminine Care Acquisition?
This transaction is another step in Essity’s strategy to expand its feminine care business.
In February 2026, Essity completed its acquisition of the North American Carefree, Stayfree, and o.b. brands from Edgewell Personal Care. Later, in August 2026, the company announced an agreement to acquire Kenvue’s Brazil-based feminine care business.
These transactions provide Essity with opportunities to strengthen its feminine care operations in both North America and Latin America.
It is important to distinguish between the two deals: the February acquisition was completed, while the acquisition of Kenvue’s Brazil business remains pending.
What Is the Connection Between the Kimberly-Clark and Kenvue Deal?
To understand this transaction properly, it is important to know about another major acquisition agreement involving Kenvue.
In November 2025, Kimberly-Clark Corporation entered into a merger agreement to acquire Kenvue. The proposed transaction was announced at an equity value of approximately $40 billion.
Under the proposed agreement, Kenvue shareholders are expected to receive the following for each Kenvue share:
- 0.14625 Kimberly-Clark shares.
- $3.50 in cash.
This is a separate merger transaction between Kimberly-Clark and Kenvue.
MTR Legal Rechtsanwälte
How Does Essity Fit Into This Transaction?
The agreement to sell Kenvue’s Brazil feminine care business to Essity was announced amid this broader corporate transaction environment.
The key points are:
- Kimberly-Clark is seeking to acquire the entire Kenvue company.
- Essity is acquiring only Kenvue’s Brazil-based feminine care business.
- Essity is not acquiring the entire Kenvue company.
These are two separate transactions with different buyers, transaction values, and acquired businesses.
Regulatory Conditions Related to the Kimberly-Clark–Kenvue Deal
Regulatory authorities in some countries have raised competition concerns about the proposed Kimberly-Clark acquisition of Kenvue, particularly in the feminine care market.
For example, on September 2, 2026, Australia’s competition regulator, the ACCC, approved the Kimberly-Clark–Kenvue acquisition subject to certain conditions. Kimberly-Clark must sell Kenvue’s Carefree and Stayfree brands in Australia to a buyer approved by the ACCC.
The European Commission also approved the Kimberly-Clark–Kenvue transaction on October 13, 2026, subject to divestment commitments.
One important point: these regulatory conditions relate to the larger Kimberly-Clark–Kenvue merger. They should not be interpreted as approval of Essity’s separate acquisition of the Brazil business.
Essity’s Q3 2026 Performance
Essity released its third-quarter 2026 financial report on October 22, 2026.
Key figures included:
| Financial Metric | Q3 2026 |
| Net Sales | SEK 36.06 Billion |
| Organic Sales Growth | -0.3% |
| EBITA | SEK 3.636 Billion |
| EBITA Excluding IAC | SEK 4.725 Billion |
| Operating Cash Flow | SEK 5.783 Billion |
| Profit for the Period | SEK 2.346 Billion |
The report also referred to the proposed acquisition of Kenvue’s Brazil feminine care business and maintained the expected closing period of Q2 2027.
Kenvue’s Q3 2026 Performance
Kenvue released its third-quarter 2026 financial results on October 30, 2026.
Key highlights included:
- Net sales increased 3.2% compared with the previous year.
- Organic sales increased 2.9%.
- Diluted EPS was $0.22.
- Adjusted diluted EPS was $0.29.
Kenvue also stated that its proposed combination with Kimberly-Clark was nearing completion. However, this statement does not confirm that Essity’s separate Brazil business acquisition has been completed.
Kenvue Reports Third Quarter 2026 Results
Main Risks and Challenges of the Acquisition
There are several factors investors and industry observers should monitor.
A. Regulatory Approval
The acquisition cannot be completed until the required regulatory approvals in Brazil and other closing conditions are satisfied. Delays in approval could affect the expected closing timeline.
B. Dependence on the Kimberly-Clark–Kenvue Merger
Essity’s transaction is also dependent on the completion of the larger Kimberly-Clark–Kenvue merger. If that transaction is delayed or a relevant condition is not satisfied, the timeline of Essity’s acquisition could be affected.
C. Brand Integration
Integrating Carefree, Sempre Livre, and o.b. into Essity’s existing portfolio will require coordination across marketing, distribution, manufacturing, and supply chain operations.
D. Competition in Brazil
Several established brands and manufacturers already operate in Brazil’s feminine care market. Essity will need to compete through pricing, product quality, distribution, and brand positioning.
E. Financial Returns
The acquired business has reported strong sales, but Essity did not disclose an exact EBITDA or net profit figure in the announcement. Therefore, it is difficult to estimate the precise financial returns of the acquisition based on the available figures alone.
What Will Essity Gain From This Deal?
This acquisition is an important part of Essity’s strategy to expand its feminine care business internationally.
The transaction will give Essity an opportunity to acquire three established brands — Carefree, Sempre Livre, and o.b. — along with related manufacturing equipment and business operations in Brazil.
The three major strategic benefits are:
- Market Expansion in Brazil: Essity will have an opportunity to strengthen its presence in the feminine hygiene category.
- Established Brands: The company will gain brands that already have recognition and customer bases in Brazil.
- Manufacturing Capabilities: Acquiring related production equipment could help strengthen local manufacturing and supply chain operations.
When considered alongside Essity’s February 2026 acquisition in North America, this transaction shows the company’s continued efforts to expand its feminine care business.
However, the success of the deal will depend on whether it closes on schedule, how effectively the brands are integrated, and how much Essity can improve its position in Brazil.
Official Sources and References
